Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms
Open Access
- 1 October 2021
- journal article
- research article
- Published by SAGE Publications in Qualitative Health Research
- Vol. 31 (14) , 2617-2628
Abstract
Critiques of antidepressants in public spaces such as print media, blogs, social media, websites, and radio and television programs are now commonplace. Such critiques typically center on issues such as the side effects and risks of antidepressants, overblown claims of effectiveness, the fallacy of the chemical imbalance hypothesis, overprescribing, and the availability of equally or more effective nonmedication interventions for depression. In this article, we employ a discursive analysis to show how online commenters fashion a particular counter-argument to these critiques. Prominent in this counter-argument is that only “real” depression benefits from antidepressants, and that a “one-size-does-not-fit-all” understanding of these medications is needed. We argue that, while this nuanced counter-critique contains features that make it difficult to undermine, it simultaneously embeds many unanswered questions.Keywords
This publication has 29 references indexed in Scilit:
- Patients’ Perspectives on Antidepressant Treatment in Consultations With PhysiciansQualitative Health Research, 2014
- Side effects of antidepressants during long-term use in a naturalistic settingEuropean Neuropsychopharmacology, 2013
- Selective Serotonin Reuptake Inhibitor Antidepressant Treatment Discontinuation Syndrome: A Review of the Clinical Evidence and the Possible Mechanisms InvolvedFrontiers in Pharmacology, 2013
- General Practitioner Management of DepressionQualitative Health Research, 2012
- “There are always two sides to these things”: Managing the dilemma of serious adverse effects from SSRIsSocial Science & Medicine, 2009
- “Medication career” or “Moral career”? The two sides of managing antidepressants: A meta-ethnography of patients' experience of antidepressantsSocial Science & Medicine, 2009
- Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug AdministrationPLOS Medicine, 2008
- A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitorsFamily Practice, 2007
- Better safe than sorry — why patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: results of a qualitative studyChronic Illness, 2006
- Research and treatment approaches to depressionNature Reviews Neuroscience, 2001